(Q39467450)

12 September 2017

1 reference

title

Evaluation and management of chronic pelvic pain (English)

1 reference

12 September 2017

0 references

Duleba AJ

1

1 reference

12 September 2017

Keltz MD

series ordinal

2

1 reference

12 September 2017

Olive DL

series ordinal

3

1 reference

12 September 2017

publication date

1 February 1996

1 reference

Journal of Minimally Invasive Gynecology

12 September 2017

published in

1 reference

12 September 2017

volume

3

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

205-227

1 reference

Pain in gynecologic practice

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

The McGill Pain Questionnaire: Major properties and scoring methods

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

The West Haven-Yale Multidimensional Pain Inventory (WHYMPI).

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Dyspareunia and vaginismus

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Management of urinary tract infections in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Clinical evaluation of CA-125 concentrations as a prognostic factor for pregnancy in infertile women with surgically treated endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Endometriosis: appearance and detection at MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Enlarged uterus: differentiation between adenomyosis and leiomyoma with MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Deeply infiltrating pelvic endometriosis: histology and clinical significance.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Laparoscopic appearances of peritoneal endometriosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Nonpigmented endometriosis: clinical, laparoscopic, and pathologic definition

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

The role of laparoscopy in chronic pelvic pain: promise and pitfalls.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. Outcome trials reviewed

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Trial of the calcium antagonist nifedipine in the treatment of primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Calcium channel blockers and dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Prostaglandins in primary dysmenorrhea. Comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Nonsteroidal anti-inflammatory drugs in perisurgical pain management. Mechanisms of action and rationale for optimum use.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Effect of an oral contraceptive in primary dysmenorrhea--changes in uterine activity and reactivity to agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Modern oral contraceptives and dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Endometriosis: treatment with gonadotropin-releasing hormone agonist Buserelin

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Hormone treatment of endometriosis: the estrogen threshold hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Efficacy and safety of nafarelin in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Insulin-dependent diabetes mellitus associated with danazol

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Nafarelin versus danazol in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Nafarelin in the treatment of pelvic pain caused by endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter, double-blind randomized clinical trial. II. Assessment of safety. The Lupron Endometriosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Endometriosis 1990. Current treatment approaches

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Cardiovascular protection by oestrogen--a calcium antagonist effect?

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Clinical features of women with chronic lower abdominal pain and pelvic congestion

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Intravenous dihydroergotamine to relieve pelvic congestion with pain in young women

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

A randomized controlled trial of medroxyprogesterone acetate and psychotherapy for the treatment of pelvic congestion

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Medroxyprogesterone acetate in the treatment of pelvic pain due to venous congestion

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Occult somatic pathology in women with chronic pelvic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Neurological factors in chronic pelvic pain: Trigger points and the abdominal pelvic pain syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Long-term use of narcotic analgesics in chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Chronic use of opioid analgesics in non-malignant pain: report of 38 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Relief of primary dysmenorrhea by transcutaneous electrical nerve stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Relationship of laparoscopic findings to self-report of pelvic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

[Pelviscopic adhesiolysis. Successes in the treatment of chronic abdominal pain caused by adhesions in the lower and middle abdomen]

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Resolution of chronic pelvic pain after laparoscopic lysis of adhesions

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

A randomized clinical trial on the benefit of adhesiolysis in patients with intraperitoneal adhesions and chronic pelvic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Initial evaluation of the use of the potassium-titanyl-phosphate (KTP/532) laser in gynecologic laparoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Operative laparoscopy with the Nd:YAG laser in the treatment of endometriosis and pelvic adhesions

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Argon laser therapy of endometriosis: a review of 92 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Nd:YAG laser ablation of early pelvic endometriosis: a report of 61 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Deep endometriosis: a consequence of infiltration or retraction or possibly adenomyosis externa?

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

A comparative histologic study on the healing process after tissue transection. I. Carbon dioxide laser and electromicrosurgery

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

A comparative histologic study on the healing process after tissue transection. II. Carbon dioxide laser and surgical microscissors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Endometriosis of the ureter

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Technical progress in pelvic surgery via operative laparoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Laparoscopic treatment of infiltrative rectosigmoid colon and rectovaginal septum endometriosis by the technique of videolaparoscopy and the CO2 laser

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Uterine leiomyomata: etiology, symptomatology, and management.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Methodical intrauterine resection.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Müllerian anomalies and their management

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

USE OF PRESACRAL SYMPATHECTOMY IN THE TREATMENT OF DYSMENORRHEA: A SECOND LOOK AFTER TWENTY-FIVE YEARS

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Presacral neurectomy for pelvic pain in infertility.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

A simplified method of laparoscopic presacral neurectomy for the treatment of central pelvic pain due to endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Presacral neurectomy for the treatment of pelvic pain associated with endometriosis: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Intractable venous sacral hemorrhage: use of stainless steel thumbtacks to obtain hemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Adhesion formation after laparoscopic surgery in tubal pregnancy: a randomized trial versus laparotomy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

The value of an absorbable adhesion barrier, Interceed, in the prevention of adhesion reformation following microsurgical adhesiolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Expanded-polytetrafluoroethylene but not oxidized regenerated cellulose prevents adhesion formation and reformation in a mouse uterine horn model of surgical injury

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

The reduction of postoperative adhesions by two different barrier methods versus control in cynomolgus monkeys: a prospective, randomized, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

Adhesion formation after tubal surgery: results of the eighth-day laparoscopy in 188 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1074-3804%2896%2980004-1

7 January 2021

10.1016/S1074-3804(96)80004-1

Identifiers

DOI

1 reference

12 September 2017

1 reference